Clinical Trial Update: Cilostazol and Nimodipine Combined Therapy After Aneurysmal Subarachnoid Hemorrhage (aSAH) [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating the combination of cilostazol and nimodipine after aneurysmal subarachnoid hemorrhage has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aneurysmal Subarachnoid Hemorrhage

Drugs mentioned

• Nimotop (nimodipine)
• Pletal (cilostazol)

Snippet

Sponsor: Henry Ford Health System | Conditions: Aneurysmal Subarachnoid Hemorrhage | Phase 4 | Status: TERMINATED